Evidence map›Paper›PMID 42573088›Full record

ArticleeLife2026

A tool to pulse-label yeast nuclear pore complexes in imaging and biochemical experiments.

Annemiek C Veldsink, Jonas S Fischer, Sophie Hell, Karsten Weis, Liesbeth M Veenhoff

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Annemiek C VeldsinkEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.ORCID https://orcid.org/0000-0001-7975-9922
Jonas S FischerInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-8652-1813
Sophie HellInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.
Karsten WeisInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0001-7224-925X
Liesbeth M VeenhoffEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.ORCID https://orcid.org/0000-0002-0158-4728

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek VI.C.192.031Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung TMAG-3_209354 CRSII5_193740
6 · The paper itself

Abstract

Nuclear pore complexes (NPCs) are key gateways to the nucleus and major organizers of genome architecture. Despite their importance, it is still not fully understood how NPCs are formed and degraded. Tools to track specific NPCs over time or under stress could unlock critical insights into these questions. Here, we demonstrate that a brief pulse of expression of a previously developed nanobody against baker's yeast nucleoporin Nup84 (Nordeen et al., 2020) enables a robust, rapid, and straightforward method for pulse-labeling NPCs in both imaging and affinity purification experiments. This approach offers an alternative to permanent, yet less rapid, genetic fluorophore- or tag-switching techniques, and provides a powerful tool for studying NPC inheritance and turnover through both microscopy and biochemical methods.

Indexed as

Nuclear PoreNuclear Pore Complex ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsStaining and LabelingSingle-Domain AntibodiesNuclear Pore Complex ProteinsNUP84 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSingle-Domain Antibodiesbiochemistrycell biologychemical biologynanobodynuclear pore complexNup84pulse-labelingS. cerevisiae

Identifiers

PMID42573088
PMCPMC13456684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.